DE2162327C3 - Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen - Google Patents

Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen

Info

Publication number
DE2162327C3
DE2162327C3 DE19712162327 DE2162327A DE2162327C3 DE 2162327 C3 DE2162327 C3 DE 2162327C3 DE 19712162327 DE19712162327 DE 19712162327 DE 2162327 A DE2162327 A DE 2162327A DE 2162327 C3 DE2162327 C3 DE 2162327C3
Authority
DE
Germany
Prior art keywords
general formula
radical
dihydro
phenyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19712162327
Other languages
German (de)
English (en)
Other versions
DE2162327B2 (de
DE2162327A1 (de
Inventor
Shigeho Takarazuka Inaba
Kikuo Ikeda Ishizumi
Masao Takarazuka Koshiba
Kazuo Kobe Mori
Hisao Nishinomiya Yamamoto
Michihiro Toyonaka Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11833270A external-priority patent/JPS4834598B1/ja
Priority claimed from JP46001477A external-priority patent/JPS4940476B1/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2162327A1 publication Critical patent/DE2162327A1/de
Publication of DE2162327B2 publication Critical patent/DE2162327B2/de
Application granted granted Critical
Publication of DE2162327C3 publication Critical patent/DE2162327C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19712162327 1970-12-23 1971-12-15 Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen Expired DE2162327C3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11833270A JPS4834598B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-12-23 1970-12-23
JP46001477A JPS4940476B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-01-19 1971-01-19
JP3489771 1971-05-21

Publications (3)

Publication Number Publication Date
DE2162327A1 DE2162327A1 (de) 1972-07-13
DE2162327B2 DE2162327B2 (de) 1975-01-30
DE2162327C3 true DE2162327C3 (de) 1975-09-18

Family

ID=27274937

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712162327 Expired DE2162327C3 (de) 1970-12-23 1971-12-15 Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen

Country Status (11)

Country Link
AU (1) AU438472B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE777102A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA981672A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH560198A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD95845A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2162327C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK129996B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2118932A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU163789B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7117652A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE405729B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) * 1991-08-16 1993-03-16 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
DE69926776T2 (de) * 1998-10-16 2006-06-08 Sumitomo Pharmaceuticals Co., Ltd. Quinalozinon-derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH515911A (de) * 1968-07-01 1971-11-30 Sandoz Ag Verfahren zur Herstellung von 3,4-Dihydro-4-phenyl-2(1H)-chinazolinonen
GB1251600A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1968-07-18 1971-10-27
DE2037693C3 (de) * 1969-08-02 1975-01-16 Sumitomo Chemical Co., Ltd., Osaka (Japan) 1-Cyclopropylmethyl-2(1 H)-chinazolinonderivate

Also Published As

Publication number Publication date
DE2162327B2 (de) 1975-01-30
AU438472B2 (en) 1973-08-09
AU3692171A (en) 1973-06-21
SE405729B (sv) 1978-12-27
FR2118932B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-10
DK129996C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-20
DE2162327A1 (de) 1972-07-13
HU163789B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-27
DK129996B (da) 1974-12-09
FR2118932A1 (en) 1972-08-04
DD95845A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-02-20
CA981672A (en) 1976-01-13
NL7117652A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-06-27
CH560198A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-27
BE777102A (fr) 1972-04-17

Similar Documents

Publication Publication Date Title
US3303199A (en) Certain imidazolone derivatives and process for making same
DE2037693A1 (de) Chinazolinderivate,verfahren zu ihrer herstellung und ihre verwendung
DE2165056C3 (de) Verfahren zur Herstellung von CMnazollnonen
DE2162327C3 (de) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
DE2141616C3 (de) Oxazole- und Oxazine eckige Klammer auf 3,2-c eckige Klammer zu chinazolinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2526983A1 (de) Pyrido/1,2-a/pyrimidinon-derivate und verfahren zu deren herstellung
DE2118315C3 (de) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2413610A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung
DE1909110A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
DE2534962C3 (de) cis-3,4-Ureylenthiophan-l,l-dioxid und Verfahren zu seiner Herstellung
DE2643127A1 (de) 2'- eckige klammer auf (3,6-dihydro-4- phenyl-1(2h)-pyridinyl- und phenyl-1-piperidinyl)-alkylaminocarbonyl eckige klammer zu - eckige klammer auf 1,1'-diphenyl eckige klammer zu -2-carbonsaeuren
DE1470367A1 (de) Verfahren zur Herstellung von in 5-Stellung substituierten 5,6-Dihydro-6-oxopyrido[2,3-b][1,4]benzoxazepinen
DE1965981C3 (de) 9-Phenyl-lO-oxopiperazino [l,2-a]-indole und Verfahren zu ihrer Herstellung
CH638525A5 (de) 3-(tetrazol-5-yl)-1-azaxanthone und verfahren zu ihrer herstellung.
EP0552758A1 (de) N-5-geschützte 2,5-Diamino-4,6-dichlorpyrimidine und Verfahren zu deren Herstellung
AT315182B (de) Verfahren zur Herstellung von Chinazolinonen
US3291824A (en) Nu-(2-halo-lower alkanoyl) anthranilic acid derivatives
EP0796251A1 (de) Uracilderivate
DD149666A1 (de) Verfahren zur herstellung von 6-amino-und 6-hydroxy-1-aryl-5-cyan-2(1h)-pyridinonen und-thionen
CH461489A (de) Verfahren zur Herstellung von neuen Oxazolderivaten
DE2166327A1 (de) 3,4-dihydro-2(1h)-chinazolinone, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2649061A1 (de) Pyrazolo eckige klammer auf 1,5-a eckige klammer zu chinoxalin-3-carbonsaeure- derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2912445A1 (de) 2-methylen-2,3-dihydro-3-oxo-4h-1,4- benzothiazin-1,1-dioxid-verbindungen, ihre herstellung und verwendung
DE2237502A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung
DE1695903A1 (de) Verfahren zur Herstellung von neuen in 11-Stellung substituierten 5,11-Dihydro-6H-pyrido[2,3-b][1,4] zu benzodiazepin-6-onen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8339 Ceased/non-payment of the annual fee